Professor Dr. Aykut Özdarendeli, Director of the Erciyes University Vaccine Research and Development Application and Research Center (ERAGEM), which developed the TURKOVAC vaccine, announced that they plan to complete the preclinical studies of the vaccine developed against Crimean-Congo Hemorrhagic Fever (CCHF) by September.
